
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Children whose diets are high in salt also drink more sugar-sweetened beverages. Together both behaviors may predict a greater risk for obesity.






